# SAM #36C10X27Q0014

VA procurement of Haemonetics Cell Saver Elite+ autotransfusion systems, supplies, service, and training

**Buyer:** VA Strategic Acquisition Center
**Posted:** November 04, 2026
**Respond By:** November 23, 2026
**Identifier:** 36C10X27Q0014
**NAICS:** 339112, 423450, 339113

The Department of Veterans Affairs is seeking Haemonetics Cell Saver Elite+ autotransfusion systems, related disposable supplies, and support for VA facilities nationwide.
- **Government buyer:** Department of Veterans Affairs (VA), Veterans Health Administration (VHA) Non-Expendable Equipment National Program; VA Enterprise Procurement Office (EPO), Strategic Acquisition Center (SAC).
- **OEM:** **Haemonetics** is the named manufacturer. Brand-name-or-equal products are acceptable if they meet the specified requirements; offerors proposing equivalents must identify the manufacturer and product details.
- **Requested products:** Estimated 20 units per year for each listed product, for the base year and each of four option years; quantities are estimates, with actual orders specifying requirements:
  - Cell Saver Elite Plus, US (CSE-EX-US).
  - Hard-shell reservoirs, 150u (00205-00) and 20u (00220-00); Basic A&A Assembly, LN 208 (00208-00); RBC bag with twist-lock connector (00245-00); 10L waste bag assembly (CSE-B-1000).
  - Elite FastPacks, 125mL (CSE-FP-125V) and 225mL (CSE-FP-225V); Elite processing kits, 125mL (CSE-P-125), 225mL (CSE-P-225), and 70mL (CSE-P-70); sequestration kit (CSE-SQ-1000); filtered vacuum line (HAR-A-1000); aspiration and anticoagulation line (HAR-A-0013).
- **Services:** Annual online recertification and a one-year Platinum Service Agreement are each estimated at 20 per year; system-operation training is estimated at 10 per year.
- **Notable requirements:** The system must collect, wash, and concentrate red blood cells for reinfusion; support applicable surgical procedures and automated processing; and provide a touchscreen interface, mobility, alarms, and safety interlocks. Disposable sets and applicable regulatory compliance are required.
- **Performance period:** A 12-month base period plus four 12-month option periods. Pricing covers annual estimates across the potential five-year term.

### Description

<div>
  <p><strong>Solicitation Number:</strong> 36C10X27Q0014<br>
  <strong>Notice Type:</strong> Combined Synopsis/Solicitation</p>

  <p>This is a combined synopsis/solicitation for brand name, or equal commercial items prepared in accordance with the format in Federal Acquisition Regulation (FAR) subpart 12.6, Streamlined Procedures for Evaluation and Solicitation for Commercial Items, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotes are being requested, and a written solicitation will not be issued.</p>

  <p>Solicitation number 36C10X27Q0014 is issued for this combined synopsis/solicitation; this solicitation is being issued as a Request for Quote (RFQ). This combined synopsis/solicitation incorporates provisions and clauses in effect through Federal Acquisition Circular (FAC) 2026-01, dated 13 March 2026.</p>

  <p><strong>Requirement Description:</strong></p>
  <p>VA has a requirement to purchase Autotransfusion Units to deliver patient care to its VA Medical Centers around the country. An Autotransfusion Unit, also known as an autologous blood recovery system, is a system that provides hospitals with an easy-to-use, reliable way to recover a patient’s own high-quality blood during medium to high blood loss procedures, including cardiac, orthopedic, trauma, transplant, vascular and OBGYN surgeries. Once recovered, the blood is washed and delivered to a product bag. The complete system is designed to be intuitive and flexible for optimal performance, supporting exceptional patient care.</p>

  <p>A single award Requirements contract will be awarded as a Brand Name or Equal in accordance with all terms, conditions, provisions, specifications, and schedule of this solicitation herein. Quotes shall contain the terms for cost/price and technical capabilities of the brand name or equal equipment. The Government reserves the right to award without discussions.</p>

  <p>The associated North American Industrial Classification System (NAICS) code for this procurement is 339112 — Surgical and Medical Instrument Manufacturing. Product Service Code: 6515 — Medical and Surgical Instruments, Equipment, and Supplies. The associated size standard is 800 employees. This procurement action is Unrestricted Full and Open.</p>

  <p>This acquisition is for a single award Requirements contract in accordance with FAR Part 16.5 for Haemonetics Call Saver® Elite® + brand name or equal to Autotransfusion Units as identified in <strong>Attachment A — Price Cost Schedule - NX EQ Autotransfusion Units</strong>. All interested companies shall provide a quote for all Contract Line-Item Numbers (CLINs) listed in that attachment.</p>

  <p>The ordering period is for one 12-month base year with four 12-month option years. Delivery is FOB destination. Firm-Fixed Price Orders will be placed against this contract in writing and will provide the delivery locations, delivery dates and exact quantities.</p>

  <p>The FAR provision at 52.212-1, Instructions to Offerors — Commercial Products and Commercial Services, applies to this acquisition, including attached addenda to the provision.</p>
  <p>The FAR provision at 52.212-2, Evaluation — Commercial Products and Commercial Services Items, and the specific evaluation criteria as attached addenda also applies to this acquisition.</p>
  <p>Clause 52.212-4, Terms and Conditions — Commercial Products and Commercial Services, applies to this acquisition, along with a statement regarding any addenda to the clause. Addendum is attached.</p>

  <p>All interested quoters must be registered in the System for Award Management (SAM) prior to submitting a quote. You may access SAM at <a href="https://sam.gov/SAM/">https://sam.gov/SAM/</a>.</p>

  <p>Questions regarding this combined synopsis/solicitation are due via email by 10:00 AM Eastern Standard Time (EST) on November 16, 2026, to Contract Specialist, Jalima Jones at <a href="mailto:Jalima.Jones@va.gov">Jalima.Jones@va.gov</a> and Contracting Officer, Sara Vickroy at <a href="mailto:Sara.Vickroy@va.gov">Sara.Vickroy@va.gov</a>.</p>
  <p><strong>No calls will be accepted.</strong> Quotes are due via email by 10:00 AM EST on November 23, 2026, to Contract Specialist, Jalima Jones at <a href="mailto:Jalima.Jones@va.gov">Jalima.Jones@va.gov</a> and Contracting Officer, Sara Vickroy at <a href="mailto:Sara.Vickroy@va.gov">Sara.Vickroy@va.gov</a>.</p>
</div>

<div>
  <p><strong>SCOPE OF WORK</strong></p>
  <p>The Veterans Health Administration (VHA) Non-Expendable Equipment National Program has identified the Autotransfusion Units product line as a candidate for a VA-wide (otherwise referred to as “national”) single Requirements contract award.</p>

  <p>Autotransfusion Units, also known as an autologous blood recovery system, provide hospitals with an easy-to-use, reliable way to recover a patient’s own high-quality blood during medium to high blood loss procedures, including cardiac, orthopedic, trauma, transplant, vascular and OBGYN surgeries. Once recovered, the blood is washed and delivered to a product bag. The complete system is designed to be intuitive and flexible for optimal performance, supporting exceptional patient care.</p>

  <p>The Contractor must demonstrate the ability to meet all requirements for the solicitation. The objective is to provide Autotransfusion Units to be used by VHA clinicians throughout the United States and its territories. The period of performance is for one 12-month base period with four 12-month option periods.</p>
</div>

<div>
  <p><strong>2. REQUIREMENT</strong></p>
  <p>This requirement will be “Brand Name or Equal,” which requires the quoter to indicate that each product being offered as an “equal” product to Haemonetics Call Saver® Elite® + or equal Autotransfusion Units. For each equal product, the quoter must include a description reflecting the salient characteristics (SCs) and level of quality that will satisfy the salient physical, functional, or performance characteristics of the equal product(s) specified in the solicitation.</p>
  <p>The quoter must also clearly identify the item by brand name (if any) and make/model number. Finally, the offeror must include descriptive literature, such as illustrations, drawings, or a clear reference to previously furnished descriptive data or information available to the Contracting Officer (CO), and clearly describe any modifications it plans to make to a product to make it conform to the solicitation requirements.</p>

  <p><strong>The following line-items comprise the Autotransfusion Units product line:</strong></p>
  <table>
    <thead>
      <tr><th>Contract Line-Item Number</th><th>Brand</th><th>Part Number</th><th>Description</th></tr>
    </thead>
    <tbody>
      <tr><td>0001</td><td>Haemonetics</td><td>00205-00</td><td>RESERVOIR, HARD-SHELL, 150u</td></tr>
      <tr><td>0002</td><td>Haemonetics</td><td>00208-00</td><td>BASIC A &amp; A ASSEMBLY, LN 208</td></tr>
      <tr><td>0003</td><td>Haemonetics</td><td>00220-00</td><td>RESERVOIR, HARD-SHELL, 20U</td></tr>
      <tr><td>0004</td><td>Haemonetics</td><td>00245-00</td><td>RBC BAG W/TWIST-LOCK CONNECTOR</td></tr>
      <tr><td>0005</td><td>Haemonetics</td><td>CSE-B-1000</td><td>BAG ASSY, WASTE, 10L</td></tr>
      <tr><td>0006</td><td>Haemonetics</td><td>CSE-FP-125V</td><td>CE ELITE FASTPACK,125mL,150u</td></tr>
      <tr><td>0007</td><td>Haemonetics</td><td>CSE-FP-225V</td><td>CS ELITE FASTPACK,225ML,150U</td></tr>
      <tr><td>0008</td><td>Haemonetics</td><td>CSE-P-125</td><td>CS ELITE PROCESSING KIT, 125ML</td></tr>
      <tr><td>0009</td><td>Haemonetics</td><td>CSE-P-225</td><td>CS ELITE PROCESSING KIT, 225ML</td></tr>
      <tr><td>0010</td><td>Haemonetics</td><td>CSE-P-70</td><td>CS ELITE PROCESSING KIT, 70ML</td></tr>
      <tr><td>0011</td><td>Haemonetics</td><td>CSE-SQ-1000</td><td>SEQUESTRATION KIT, CSE-SQ-1000</td></tr>
      <tr><td>0012</td><td>Haemonetics</td><td>HAR-A-1000</td><td>VACUUM LINE, FILTERED</td></tr>
      <tr><td>0013</td><td>Haemonetics</td><td>HAR-A-0013</td><td>ASPIRATION &amp; ANTICOAG LINE</td></tr>
      <tr><td>0014</td><td>Haemonetics</td><td>CSE-EX-US</td><td>CELL SAVER ELITE PLUS, US</td></tr>
      <tr><td>0015</td><td>Haemonetics</td><td>RECERTIFICATION</td><td>ANNUAL ONLINE RECERTIFICATION</td></tr>
      <tr><td>0016</td><td>Haemonetics</td><td>Cell saver Service</td><td>1 Year Platinum Service Agreement</td></tr>
      <tr><td>0017</td><td>Haemonetics</td><td>Training Tuition</td><td>Training</td></tr>
    </tbody>
  </table>

  <p>The Department of Veterans Affairs (VA) is seeking vendors who can provide Haemonetics Call Saver® Elite® + brand name or equal Autotransfusion Units as listed above, which meet all the following salient characteristics.</p>
  <p>Vendors may quote any product solution or configuration so long as they meet the salient characteristics. Products quoted in the technical volume must be captured on the Vendor’s pricing volume (Attachment A, Price Cost Schedule) of the solicitation. Vendors may quote any additional ancillary products which they deem to be essential to the functionality of the proposed solution; these items must be captured in the Vendor’s pricing volume with a quantity of zero.</p>

  <table>
    <thead>
      <tr><th>SC #</th><th>Salient Characteristics</th><th>Method of Evaluation</th><th>Applicable CLINs</th><th>Page # Where SC is Found in Technical Literature</th></tr>
    </thead>
    <tbody>
      <tr><td>SC1</td><td>Collects, separates, washes, and concentrates red blood cells to produce packed RBCs for reinfusion.</td><td>Literature Review</td><td>0014</td><td></td></tr>
      <tr><td>SC2</td><td>Provides multiple automated processing modes (standard, low volume/pediatric, rapid/emergency) with defined throughput/output rates that support continuous or rapid access to washed RBCs during surgery.</td><td>Literature Review</td><td>0014</td><td></td></tr>
      <tr><td>SC3</td><td>Produces high hematocrit washed RBCs with high RBC recovery, achieving a strong removal of non-RBC components (plasma proteins, free hemoglobin, anticoagulant, potassium, fat).</td><td>Literature Review</td><td>0014</td><td></td></tr>
      <tr><td>SC4</td><td>Provides an intuitive touchscreen user interface with guided workflows and clear process/status indicators.</td><td>Literature Review</td><td>0014</td><td></td></tr>
      <tr><td>SC5</td><td>Compact, mobile system suitable for OR environments, with ergonomic features that support perfusionist/autotransfusionist workflow.</td><td>Literature Review</td><td>0014</td><td></td></tr>
      <tr><td>SC6</td><td>Includes alarms and safety interlocks for process parameters, vacuum, fluid levels, and product quality, with reliability appropriate for high-use OR settings.</td><td>Literature Review</td><td>0014</td><td></td></tr>
      <tr><td>SC7</td><td>Cleared/approved as an autotransfusion device under applicable regulations and standards.</td><td>Literature Review</td><td>0014</td><td></td></tr>
      <tr><td>SC8</td><td>Uses single-use disposable sets that are quick to install and prime, minimizing setup time and steps.</td><td>Literature Review</td><td>0001–0013</td><td></td></tr>
      <tr><td>SC9</td><td>Supports intraoperative and postoperative autologous blood collection, processing, and reinfusion for medium to high blood loss procedures (cardiac, orthopedic, trauma, vascular, transplant, OBGYN).</td><td>Literature Review</td><td>0001–0014</td><td></td></tr>
    </tbody>
  </table>

  <p>The following attachments are incorporated by reference. All criteria outlined in the attachments are applicable to this combined synopsis/solicitation.</p>
</div>

<div>
  <p><strong>Additional Links:</strong></p>
  <ul>
    <li><a href="https://www.va.gov/opal/sac/index.asp" target="_blank">VA | OALC | OPAL | SAC</a></li>
  </ul>
</div>

[View original listing](https://sam.gov/opp/62f20267713b4d5090ed31de5f2ad78a/view)